Thiazolidinediones (TZD) are high affinity synthetic agonists for PPARγ that improve glycemic control in type 2 diabetes, and have been reported to improve vascular function and to lower arterial pressure [2] (reviewed in [3]). The gene discussed is PPARG; the disease is type 2 diabetes mellitus.